Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1720

1.

Evolution in clinical presentation of inflammatory bowel disease over time at diagnosis: a multicenter cohort study.

Nahon S, Ramtohul T, Paupard T, Belhassan M, Clair E, Abitbol V.

Eur J Gastroenterol Hepatol. 2018 Jul 12. doi: 10.1097/MEG.0000000000001201. [Epub ahead of print]

PMID:
30004906
2.

Position Statement for the Management of Comorbidities in Psoriasis.

Dauden E, Blasco AJ, Bonanad C, Botella R, Carrascosa JM, González-Parra E, Jodar E, Joven B, Lázaro P, Olveira A, Quintero J, Rivera R.

J Eur Acad Dermatol Venereol. 2018 Jul 10. doi: 10.1111/jdv.15177. [Epub ahead of print]

PMID:
29992631
3.

Risk factors for inflammatory bowel disease: A prospective multi-center study.

Amarapurkar AD, Amarapurkar DN, Rathi P, Sawant P, Patel N, Kamani P, Rawal K, Baijal R, Sonawane A, Narawane N, Kolekar S, Totla N.

Indian J Gastroenterol. 2018 Jul 9. doi: 10.1007/s12664-018-0850-0. [Epub ahead of print]

PMID:
29987750
4.

Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.

Park YE, Cheon JH, Park JJ, Kim YJ, Choi CH, Park Y, Park SJ, Kim TI, Kim WH.

Int J Colorectal Dis. 2018 Jul 9. doi: 10.1007/s00384-018-3123-6. [Epub ahead of print]

PMID:
29987360
5.

Anxiety, depression, and inflammation after restorative proctocolectomy.

Gorrepati VS, Yadav S, Stuart A, Koltun W, Messaris E, Williams ED, Coates MD.

Int J Colorectal Dis. 2018 Jun 29. doi: 10.1007/s00384-018-3110-y. [Epub ahead of print]

PMID:
29959529
6.

Nicotine treatment ameliorates DSS-induced colitis by suppressing MAdCAM-1 expression and leukocyte recruitment.

Maruta K, Watanabe C, Hozumi H, Kurihara C, Furuhashi H, Takajo T, Okada Y, Shirakabe K, Higashiyama M, Komoto S, Tomita K, Nagao S, Ishizuka T, Miura S, Hokari R.

J Leukoc Biol. 2018 Jun 14. doi: 10.1002/JLB.3A0717-304R. [Epub ahead of print]

PMID:
29901817
7.

Association between smoking and risk of primary sclerosing cholangitis: A systematic review and meta-analysis.

Wijarnpreecha K, Panjawatanan P, Mousa OY, Cheungpasitporn W, Pungpapong S, Ungprasert P.

United European Gastroenterol J. 2018 May;6(4):500-508. doi: 10.1177/2050640618761703. Epub 2018 Feb 21.

8.

Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials.

Singh S, Proudfoot J, Xu R, Sandborn WJ.

Am J Gastroenterol. 2018 Jun;113(6):883-889. doi: 10.1038/s41395-018-0104-x. Epub 2018 Jun 5.

PMID:
29867171
9.

Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA.

Wang P, Hu J, Ghadermarzi S, Raza A, O'Connell D, Xiao A, Ayyaz F, Zhi M, Zhang Y, Parekh NK, Lazarev M, Parian A, Brant SR, Bedine M, Truta B, Hu P, Banerjee R, Hutfless SM.

Dig Dis Sci. 2018 Jun 4. doi: 10.1007/s10620-018-5142-0. [Epub ahead of print]

PMID:
29862485
10.

The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.

Anderson A, Click B, Ramos-Rivers C, Koutroubakis IE, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A 3rd, Regueiro M, Binion DG.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1380-1388. doi: 10.1093/ibd/izy040.

PMID:
29860492
11.

Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics.

Li D, Haritunians T, Landers C, Potdar AA, Yang S, Huang H, Schumm LP, Daly M, Targan SR, McGovern DPB.

Inflamm Bowel Dis. 2018 May 30. doi: 10.1093/ibd/izy148. [Epub ahead of print]

PMID:
29860388
12.

Gender differences in chronic obstructive pulmonary diseases: a narrative review.

Nicolini A, Barbagelata E, Tagliabue E, Colombo D, Monacelli F, Braido F.

Panminerva Med. 2018 Jun 1. doi: 10.23736/S0031-0808.18.03463-8. [Epub ahead of print]

PMID:
29856178
13.

Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.

Sofia MA, Ciorba MA, Meckel K, Lim CK, Guillemin GJ, Weber CR, Bissonnette M, Pekow JR.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1471-1480. doi: 10.1093/ibd/izy103.

PMID:
29796641
14.

Prevalence and Associations of Avascular Necrosis of the Hip in a Large Well-characterized Cohort of Patients With Inflammatory Bowel Disease.

Rolston VS, Patel AV, Learch TJ, Li D, Karayev D, Williams C, Siddanthi ML, Targan SR, Weisman MH, McGovern DPB.

J Clin Rheumatol. 2018 May 24. doi: 10.1097/RHU.0000000000000797. [Epub ahead of print]

PMID:
29794876
15.

Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease.

Navabi S, Gorrepati VS, Yadav S, Chintanaboina J, Maher S, Demuth P, Stern B, Stuart A, Tinsley A, Clarke K, Williams ED, Coates MD.

Inflamm Bowel Dis. 2018 May 17. doi: 10.1093/ibd/izy143. [Epub ahead of print]

PMID:
29788469
16.

Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-Anal Anastomosis.

Gorrepati VS, Stuart A, Deiling S, Koltun W, Tinsley A, Williams ED, Coates MD.

Inflamm Bowel Dis. 2018 May 17. doi: 10.1093/ibd/izy097. [Epub ahead of print]

PMID:
29788269
17.

Impact of Obesity on Short- and Intermediate-Term Outcomes in Inflammatory Bowel Diseases: Pooled Analysis of Placebo Arms of Infliximab Clinical Trials.

Singh S, Proudfoot J, Xu R, Sandborn WJ.

Inflamm Bowel Dis. 2018 May 18. doi: 10.1093/ibd/izy135. [Epub ahead of print]

PMID:
29788260
18.

Perioperative blood transfusion is associated with post-operative infectious complications in patients with Crohn's disease.

Lan N, Stocchi L, Li Y, Shen B.

Gastroenterol Rep (Oxf). 2018 May;6(2):114-121. doi: 10.1093/gastro/gox023. Epub 2017 May 30.

19.

A prospective study to monitor for tuberculosis during anti-tumour necrosis factor therapy in patients with inflammatory bowel disease and immune mediated inflammatory diseases.

Lee CK, Wong SH, Lui G, Tang W, Tam LS, Ip M, Hung E, Chen M, Wu JC, Ng SC.

J Crohns Colitis. 2018 May 11. doi: 10.1093/ecco-jcc/jjy057. [Epub ahead of print]

PMID:
29757355
20.

Epigenome-Wide Association Study of Soluble Tumor Necrosis Factor Receptor 2 Levels in the Framingham Heart Study.

Mendelson MM, Johannes R, Liu C, Huan T, Yao C, Miao X, Murabito JM, Dupuis J, Levy D, Benjamin EJ, Lin H.

Front Pharmacol. 2018 Apr 24;9:207. doi: 10.3389/fphar.2018.00207. eCollection 2018.

Supplemental Content

Loading ...
Support Center